Home › Funds › Brookstone Capital Management › JNJ

Brookstone Capital Management position in JNJ

JOHNSON & JOHNSON · Health Care

Brookstone Capital Management reported holding 175,974 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$46.6M, representing 0.49% of its reported portfolio and ranking #44 among its reported holdings. Brookstone Capital Management has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)175.97K sh
Reported value held$46.59M
Portfolio Weight0.49%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Brookstone Capital Management's JNJ position evolved

Brookstone Capital Management first disclosed a stake in JNJ in Q3 2023 at 68,596 shares (US$10.4M). The position peaked in Q2 2026 at 184,287 shares, worth US$46.8M. Across 13 filings, Brookstone Capital Management increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 175,974 shares valued at US$46.6M — a reduction of -8,313 shares quarter over quarter.. Notable position changes include a 138% increase in Q2 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 68.60K $10.45M New
Q4 2023 69.28K $10.86M Add
Q1 2024 86.52K $13.69M Add
Q2 2024 69.97K $10.96M Reduce
Q3 2024 73.81K $11.96M Add
Q4 2024 72.34K $10.46M Reduce
Q1 2025 73.54K $12.20M Add
Q2 2025 75.43K $11.52M Add
Q3 2025 71.22K $13.21M Reduce
Q4 2025 72.04K $14.91M Add
Q1 2026 77.48K $18.94M Add
Q2 2026 184.29K $46.80M Add
Q3 2026 175.97K $46.59M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Brookstone Capital Management held JNJ?

Brookstone Capital Management has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Brookstone Capital Management's current position in JNJ?

As of Q3 2026, Brookstone Capital Management holds 175.97K shares of JNJ (JOHNSON & JOHNSON), valued at $46.59M, representing 0.49% of its reported portfolio and ranking #44.

Has Brookstone Capital Management been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Brookstone Capital Management reduced its position in JNJ. The position peaked in Q2 2026 at 184.29K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.